IW Logo The MFWire
| My Account | About MFWire | Who We Are | Advertise
IW IW
      The insiders' edge for '40 Act industry executives!    An InvestmentWires Pub 
IW
                                  

Meet the Reporters

MFWire has a team of journalists dedicated to helping our members understand the mutual fund business. To reach them with story ideas simply email editors "at" investmentwires.com or call us directly at 212-331-8995.

  • Sean  Hanna

  • Editor-in-Chief
    Sean is the founding publisher of InvestmentWires. Prior to 1997, he was an editor at New York City-based IOMA (now a part of BNA) where he oversaw IOMA's DC Plan Investing, the first publication to exclusively cover the 401(k) industry in 1992. He has spoken at industry conferences as an expert on the financial services industry, made appearances on CNBC and been quoted in numerous financial publications, including Money Magazine and the Wall Street Journal. He studied history at Cornell University in Ithaca, New York. Sean is responsible for all editorial appearing on MFWire.



  • Neil  Anderson

  • Managing Editor
    Before joining InvestmentWires, Neil worked as a string reporter for Suburban News Publications in Columbus, Ohio, where he covered local schools and politics. He holds a B.A. in Economics and Political Science from Williams College. While at Williams, he wrote for and edited the campus humor magazine, The Mad Cow, and he wrote for The Williams Record. Neil is responsible for the day-to-day editorial oversight of MFWire. He also covers advisors for MFWire.



  • Selma  Khenissi

  • Reporter
    Prior to joining InvestmentWires, Selma reported on pharmaceuticals, medical devices and the FDA for WCG – FDAnews. She holds a Master of Professional Studies degree in Journalism from Georgetown University and studied English at the University of Maryland’s College Park campus. Selma reports primarily for MFWire's sister publication 401kWire.
         

Sign Up



Contact Veronica Guzman at
sales@mfwire.com or
call 212-331-8999 for a
no risk trial.
MFWire Insight home